| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8B | $11.7B | $9.1B | $5.1B | $5.3B | $1.4B | $1.1B | $0.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.7B | $1.9B | $2.6B | $-1.1B | $-0.0B | $0.2B | $0.0B | $-0.1B |
| EPS (Basic) | $56.23 | $35.31 | $52.40 | $-25.50 | $-1.57 | $3.75 | $0.77 | $-2.10 |
| EPS (Diluted) | $56.03 | $35.21 | $52.27 | $-25.50 | $-1.57 | $3.74 | $0.77 | $-2.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $53.8B | $50.7B | $49.0B | $36.6B | $34.0B | $30.8B | $26.3B | $18.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.7B | $1.7B | $1.9B | $1.2B | $1.9B | $1.7B | $1.4B | $1.1B |
| Total Liabilities | $34.6B | $33.2B | $33.5B | $26.7B | $23.8B | $19.9B | $17.3B | $11.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.6B | $10.6B | $9.5B | $5.3B | $6.6B | $7.6B | $6.0B | $5.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $4.2B | $1.9B | $1.6B | $1.2B | $2.0B | $2.1B | $1.2B |
| Investing Cash Flow | $-2.2B | $-3.1B | $-3.8B | $-3.0B | $-0.8B | $-2.3B | $-3.0B | $-2.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.4B | $-1.3B | $2.6B | $0.7B | $-0.3B | $0.7B | $1.1B | $1.1B |